Medecine et Developpements SRL
Medecine et Developpements reported total assets of 205,602 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Oct 2026).
The score of Medecine et Developpements shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +79 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medecine et Developpements's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Oct 2026
- Year ended 31 Dec 2024filed on 23 Nov 2025
- Year ended 31 Dec 2023filed on 30 Oct 2024
- Year ended 31 Dec 2022filed on 30 Oct 2023
- Year ended 31 Dec 2021filed on 26 Nov 2022
Medecine et Developpements's financial analysis
- Solvency9.8%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medecine et Developpements
Medecine et Developpements's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0756.920.494
- VAT number
- BE0756920494
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 23 Oct 2020
- Registered office
- 4630 Soumagne
- Latest accounts
- 2025 · filed on 08 Oct 2026
- Activity
- General medical practice activities (NACE 86210)
Medecine et Developpements (SRL) has been based in Soumagne since 2020, active in: general medical practice activities. For 2025, it reports a net profit of 7,163 € and equity of 20,179 €; its revenue is not published. Its solvency stands at 9.8%, below the median of its sector (65.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medecine et Developpements
Companies in the same business, of comparable size and area, outside its group.
- Infi Béatrice Niangi Nursing and midwifery activities Liège · balance sheet 205,623 €
- Chembo Manufacture of soap and detergents, cleaning and polishing preparations Tournai · balance sheet 205,513 €
- Inducom Fontaine-l'Évêque · balance sheet 205,718 €
- CHUR Ixelles · balance sheet 205,481 €
- R.O.E.L. Motion picture, video and television programme post-production activities Tremelo · balance sheet 205,776 €
- Biladam Transport Scheduled passenger transport by road Anderlecht · balance sheet 205,424 €
- RC Immo Invest Visé · balance sheet 205,553 €
- Cabinet Medical Docteur Thierry Baudoux S.C.SPRL Visé · balance sheet 205,532 €
Frequently asked questions about Medecine et Developpements
What is the revenue of Medecine et Developpements?
Medecine et Developpements files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medecine et Developpements?
In Belgium, the VAT number is the company number prefixed with BE: BE0756920494 for Medecine et Developpements, if the company is VAT-registered. Its company number (CBE) is 0756.920.494.
Where is the registered office of Medecine et Developpements?
According to the CBE register, the registered office of Medecine et Developpements is in 4630 Soumagne.
What is the equity of Medecine et Developpements?
At the close of the 2025 financial year, the equity of Medecine et Developpements amounts to 20,179 €, a solvency of 9.8% of total assets.
Who manages Medecine et Developpements?
The register lists 1 active mandates at Medecine et Developpements. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medecine et Developpements
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →